Navigation Links
Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Date:3/31/2009

Gregory P. Samsa, associate professor at Duke University Medical Center and co-investigator of the study. "These results are consistent with several other analyses showing that many atrial fibrillation patients who are at increased risk for stroke do not receive treatment with anticoagulants."

About Atrial Fibrillation

Atrial fibrillation is a disorder in which the normally regular and coordinated contraction pattern of the heart's two small upper chambers (the atria) becomes irregular and uncoordinated. The contraction pattern associated with AF causes blood to pool up in the atria predisposing to formation of clots, which may escape from the heart and become lodged in the arteries leading to the brain and other organs blocking necessary blood flow. Many people with the disorder do not experience any symptoms but some may feel heart palpitations, shortness of breath, dizziness or fatigue.(9)

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of U.S. $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines
2. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
3. Final Patient Completes Treatment In Boehringer Ingelheims RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
4. Health Plans Increase Use of Health Incentives
5. Area Health Care Providers Announce Plans to Integrate Services
6. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
7. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
8. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
9. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
10. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
11. Delta Dental Plans Association Forms National Scientific Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... more likely to try alcohol, illegal drugs , , THURSDAY, ... smoking cigarettes is riskier than using illicit drugs or ... perception may increase the likelihood that they,ll experiment with ... "We are on the right track with cigarette smoking ... the dangers of other substances," Pamela S. Hyde, administrator ...
(Date:12/17/2009)... nurses now able to access trusted medical information using virtually ... ... MA (PRWEB) December 17, 2009 -- Skyscape, Inc., the world’s ... and the Internet, has launched a mobile clinical decision application ... are now available on most smart phone devices, making the ...
(Date:12/17/2009)... 17 Reportlinker.com announces that a ... its catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ... the animal health industry executives with strategically ... to the development and implementation of effective ... objectives include: ,, To establish ...
(Date:12/17/2009)... Today, CDC,s Morbidity and Mortality Weekly Report (MMWR) ... state-level epidemiologists has decreased steadily since 2004, with ... There was also a substantial decrease in core ... capacity for bioterrorism and emergency response. ... health, substance abuse, and oral health, basic epidemiology ...
(Date:12/17/2009)... -- Good Samaritan Hospital is changing the way women ... launch of the Good Samaritan Hospital Women,s Center For ... to help treat two common medical problems - lack ... bladder, uterus or rectum (pelvic organ prolapse). Three out ... and one out of three may experience pelvic organ ...
Breaking Medicine News(10 mins):Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 3Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 4Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3
... NEW YORK, July 3 Attorneys representing more than ... recovery and debris clean-up personnel who became ill after ... site following the collapse,of the World Trade Center Towers ... responsible for the litigation of those cases that the ...
... of disease in developing countries, study suggests, , , THURSDAY, ... where breast-feeding is a necessity, and HIV is rampant, ... be reduced if infants were first fed a freeze-dried ... potentially destroy the deadly virus. , But that hope ...
... July 3 Dr. Thomas Hassell, former,global vice ... leading,vaccine company, has joined IAVI as vice president ... will lead IAVI,s product development efforts,that are aimed ... the organization,s vaccine discovery programs., Dr. Hassell ...
... Senators,Hutchison and Cornyn for blocking bill to protect ... July 3 AARP Texas joined,forces today with ... Bailey,Hutchison and John Cornyn to reconsider and support ... cut to doctors who treat Medicare patients, keep,Medicare ...
... NEW YORK, July 3 Mergent, Inc., administrator ... indexes for the,HealthShares(TM) Exchange Traded Funds, today announced ... on Wednesday July 9, 2008: ISTA,Pharmaceuticals (Nasdaq: ... in the HealthShares(TM) Ophthalmology Index. Jerini AG is ...
... benefits of restricted calorie diets, study finds , , THURSDAY, ... in red wine known as resveratrol appears to protect ... old, new animal research reveals. , "It,s very hard ... benefits of red wine directly, because red wine has ...
Other Medicine News:Health News:9/11 Workers Refute City's Allegation of Discovery Abuse and Malingering 2Health News:9/11 Workers Refute City's Allegation of Discovery Abuse and Malingering 3Health News:Freeze-Dried Formula May Block HIV Virus in Breast Milk 2Health News:Leading Vaccine Expert Joins IAVI 2Health News:Leading Vaccine Expert Joins IAVI 3Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 2Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 3Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index 2Health News:Compound in Red Wine Fights Ravages of Age 2Health News:Compound in Red Wine Fights Ravages of Age 3
(Date:12/16/2009)... According to Millennium Research Group (MRG), the global ... US minimally invasive spinal fusion market will expand ... 12% through 2014, reimbursement concerns in certain segments ... previously had been forecast at almost 20%. ,, ... Technologies 2010 report finds that ...
(Date:12/16/2009)... Wound Management Technologies, Inc. (OTC ... of specialty medical products, announced today that ... toward productization of its patented orthopedic bone ... products to be introduced in Q3 2010, ... a multi-billion dollar international market. ,, "Resorbable ...
(Date:12/16/2009)... 16 DATATRAK International, Inc. (OTCQX: ... on global eClinical solutions for the clinical ... its version 9.0 eClinical Software. This ... product and service delivery and introduces two ... offering: the DATATRAK Learning Center(TM) and the ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 1Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 3Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 5FREE Wash Your Hands Song from Edutunes com Teaches Children How to Stay Healthy 47694 1Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 1Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 2Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: